Vector Space Biosciences

Vector Space Biosciences, Inc., (SBIO), parent company of Vectorspace AI (VXV), along with its scientific collaborators, launch biological CubeSats for purpose of generating data related to microgravity and radiation. This data leads to the development of countermeasures against diseases associated to stressors connected to protecting and repairing the human body during spaceflight. This includes using a network of scientific data engineering pipelines for building targeted language models resulting in real-time datasets which power Artificial Intelligence (AI) operations in space biosciences, biotechnology and pharmaceutical development. Working with leading scientific labs in the areas of human aging, cancer, and nutrigenomics, our goal is to accelerate the process of new hypothesis generation and novel discoveries in space biosciences, including materials sciences in the area of nanotechnology and nanomedicines. Developing advanced large and small language modeling technologies, our platform is capable of producing more than 100,000,000,000 different real-time datasets for the purpose of accelerating discoveries. Innovations in space biosciences result in products and services for all industries, including the financial markets, more importantly, new forms of precision medicine for all humankind.

网站

https://vectorspacebio.science/

Vector Space Biosciences的外部链接

所属行业

空间科学研究与技术

规模

11-50 人

总部

La Jolla，California

类型

私人持股

创立

2018

领域

Artificial Intelligence、Predictive Analytics、 Machine Learning、NLP、Natural Language Processing、NLU、Natural Language Understanding、Datasets、Data science、Language Modeling和Space Biosciences